These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8177042)

  • 1. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow.
    Nishina PM; Lowe S; Wang J; Paigen B
    Metabolism; 1994 May; 43(5):549-53. PubMed ID: 8177042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow.
    Nishina PM; Naggert JK; Verstuyft J; Paigen B
    Metabolism; 1994 May; 43(5):554-8. PubMed ID: 8177043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice.
    Coleman DL; Schwizer RW; Leiter EH
    Diabetes; 1984 Jan; 33(1):26-32. PubMed ID: 6228478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of age on the development of hypertriglyceridaemia and hypercholesterolaemia in genetically diabetic mice.
    Tuman RW; Doisy RJ
    Diabetologia; 1977 Jan; 13(1):7-11. PubMed ID: 838204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding.
    Kobayashi K; Forte TM; Taniguchi S; Ishida BY; Oka K; Chan L
    Metabolism; 2000 Jan; 49(1):22-31. PubMed ID: 10647060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of glycemic and lipid levels in db/db diabetic mice by psyllium plant fiber.
    Watters K; Blaisdell P
    Diabetes; 1989 Dec; 38(12):1528-33. PubMed ID: 2555240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia.
    Lucas CP; Boldrin MN; Reaven GM
    Am J Cardiol; 2003 Apr; 91(8):961-4. PubMed ID: 12686336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide content in pancreas and pituitary of obese and diabetes mutant mice: strain and sex differences.
    Timmers K; Coleman DL; Voyles NR; Powell AM; Rökaeus A; Recant L
    Metabolism; 1990 Apr; 39(4):378-83. PubMed ID: 1691431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice.
    Xiong WT; Gu L; Wang C; Sun HX; Liu X
    J Ethnopharmacol; 2013 Dec; 150(3):935-45. PubMed ID: 24095831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta).
    Hannah JS; Verdery RB; Bodkin NL; Hansen BC; Le NA; Howard BV
    J Clin Endocrinol Metab; 1991 May; 72(5):1067-72. PubMed ID: 2022707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.
    Fujioka S; Matsuzawa Y; Tokunaga K; Tarui S
    Metabolism; 1987 Jan; 36(1):54-9. PubMed ID: 3796297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of associated conditions on glycemic control of NIDDM patients.
    Ferrannini E; Stern MP; Galvan AQ; Mitchell BD; Haffner SM
    Diabetes Care; 1992 Apr; 15(4):508-14. PubMed ID: 1499466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
    Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
    Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric analysis of obesity (ob/ob)- and diabetes (db/db)-associated hypothalamic neuronal degeneration in C57BL/KsJ mice.
    Garris DR
    Brain Res; 1989 Oct; 501(1):162-70. PubMed ID: 2804691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile.
    Poirier B; Bidouard JP; Cadrouvele C; Marniquet X; Staels B; O'Connor SE; Janiak P; Herbert JM
    Diabetes Obes Metab; 2005 Jan; 7(1):65-72. PubMed ID: 15642077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test.
    Martins IJ; Tran JM; Redgrave TG
    J Nutr; 2002 Feb; 132(2):176-81. PubMed ID: 11823575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma glucose, insulin and lipids during growth of genetically lean and obese swine.
    Mersmann HJ; Pond WG; Yen JT
    Growth; 1982; 46(3):189-98. PubMed ID: 6757063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid responses to a eucaloric high-complex carbohydrate diet in different obesity phenotypes.
    Roust LR; Kottke BA; Jensen MD
    Mayo Clin Proc; 1994 Oct; 69(10):930-6. PubMed ID: 7934189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.